References
- CelliBRDecramerMWedzichaJAAn official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015191e4e2725830527
- VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryEur Respir J201749170021428182564
- Istituto Superiore di SanitàIl Fumo in Italia 2015 [Smoking in Italy in 2015]2015 Available from: http://www.progettocitex.it/wp-content/uploads/2015/06/ISS-Rapporto-Fumo-2015.pdfAccessed March 1, 2017 Italian
- OsmanLMDouglasJGGardenCIndoor air quality in homes of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717646547217507547
- EisnerMDBalmesJYelinEHDirectly measured secondhand smoke exposure and COPD health outcomesBMC Pulm Med200661216756671
- MelvilleAMPless-MulloliTAfolabiOAStentonSCCOPD prevalence and its association with occupational exposures in a general populationEur Respir J20103648849320110401
- SalviSSBarnesPJChronic obstructive pulmonary disease in nonsmokersLancet200937473374319716966
- SorianoJBZielinskiJPriceDScreening for and early detection of chronic obstructive pulmonary diseaseLancet200937472173219716965
- LindbergABjerg-BäcklundARönmarkELarssonLGLundbäckBPrevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking: report from the Obstructive Lung Disease in Northern Sweden studiesRespir Med200610026427215975774
- ZielinskiJBednarekMEarly detection of COPD in a high-risk population using spirometric screeningChest200111973173611243950
- DuvallKFrankGWIdentifying chronic obstructive pulmonary disease in primary care of urban underserved patients: tools, applications, and challengesJ Natl Med Assoc201010257057820690320
- van den BoomGRutten-van MölkenMPTirimannaPRvan SchayckCPFolgeringHvan WeelCAssociation between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programmeEur Respir J19981167729543272
- TantucciCModinaDLung function decline in COPDInt J Chron Obstruct Pulmon Dis20127959922371650
- DrummondMBHanselNNConnettJEScanlonPDTashkinDPWiseRASpirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851301130622561963
- HudgelDWPettyTLBaidwanBHarrisonAA community pulmonary disease screening effort: “Denver lung days”Chest197874619623738118
- SchohRJFeroLJShapiroHPerformance of a new screening spirometer at a community health fairRespir Care2002471150115712354333
- TibertiSMaseduFValentiMBPCO: studio trasversale di prevalenza e programma di screening in un’area a rischio nel delta del Po [COPD: cross-sectional study of prevalence and screening program in a risk area of the Po River delta in Italy]Ann Ig201022583599 Italian21425655
- CricelliCMazzagliaGSamaniFPrevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databasesJ Public Health Med20032525425714575204
- ViegiGMatteelliGAnginoAThe proportional Venn diagram of obstructive lung disease in the Italian general populationChest20041261093110115486369
- BelleudiVAgabitiNKirchmayerUDefinizione e validazione di un modello predittivo per l’identificazione di pazienti affetti da broncopneumopatia cronica ostruttiva (BPCO) a partire dai sistemi informativi sanitari [Definition and validation of a predictive model to identify patients with chronic obstructive pulmonary disease (COPD) from administrative databases]Epidemiol Prev201236162171 Italian22828229
- European Environment AgencyAir Quality in Europe – 2016 ReportCopenhagenEEA2016
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
- LeeCKahendeJFactors associated with successful smoking cessation in the United States, 2000Am J Public Health2007971503150917600268
- US Food and Drug AdministrationSummary of safety and effectiveness: Spirolab II2006 Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf5/K052140.pdfAccessed March 1, 2017
- PerilloMBoschettiPSSpirolab II User’s Manual Revision 2Waukesha (WI)Medical International Research2001
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
- QuainerPHStandardized lung function testingBull Eur Physiopathol Respir1983191956616097
- TavakolMDennikRMaking sense of Cronbach’s alphaInt J Med Educ20112535528029643
- Puglia: Libro Bianco. Esperienze di gestione delle malattie respiratorie nella regione Puglia. Tendenze Nuove n.1-2015 [Puglia: White Paper. Experiences in management of respiratory diseases in the Puglia region. New tendencies n.1-2015] Passoni Editore. Available from: http://www.fsk.it/attach/Content/Tendenzenuove/5836/o/tendenze_0115.pdfAccessed June 1, 2016 Italian
- Approvazione percorso diagnostico terapeutico per la diagnosi e la terapia di ASMA e BPCO [Approval of a therapeutic and diagnostic path for diagnosis and therapy of ASMA and COPD]2013 Available from: http://www.forumriskmanagement.it/images/FORUMRISK11/LABORATORIO-PDTA/REGIONI/PUGLIA/Deliberazione_Giunta_regionale_PDTA_BPCO_2013.pdfAccessed March 1, 2017 Italian
- McIvorRATashkinDPUnderdiagnosis of chronic obstructive pulmonary disease: a rationale for spirometry as a screening toolCan Respir J2001815315811420591
- Van SchayckCPLoozenJMWagenaEAkkermansRPWesselingGJDetecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding studyBMJ2002324137012052807
- van den BoomGvan SchayckCPvan MöllenMPActive detection of chronic obstructive pulmonary disease and asthma in the general population: results and economic consequences of the DIMCA programAm J Respir Crit Care Med1998158173017389847260
- KidaKWakabayashiRMizuuchiTMurataAScreening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q)Intern Med2006451201120717139118
- ZhongNWangCYaoWPrevalence of chronic obstructive pulmonary disease in China: a large, population-based surveyAm J Respir Crit Care Med200717675376017575095
- OharJASadeghnejadAMeyersDADonohueJFBleeckerERDo symptoms predict COPD in smokers?Chest20101371345135320363841
- BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and underdiagnosis of COPD in the primary care settingThorax20086340240718234906
- WhittemoreASPerlinSADi CiccioYChronic obstructive pulmonary disease in lifelong nonsmokers: results from NHANESAm J Public Health1995857027067733432
- BirringSSBrightlingCEBraddingPClinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive studyAm J Respir Crit Care Med20021661078108312379551
- PeñaVSMiravitllesMGabrielRGeographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological studyChest200011898198911035667
- SiuALBibbins-DomingoKGrossmanDCScreening for chronic obstructive pulmonary disease: US Preventive Services Task Force Recommendation StatementJAMA20163151372137727046365
- BuistASConnettJEMillerRDKannerREOwensGRVoelkerHTChronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study): baseline characteristics of randomized participantsChest1993103186318728404115
- MartinezCHKimVChenYThe clinical impact of non-obstructive chronic bronchitis in current and former smokersRespir Med201410849149924280543
- van der MolenTWillemseBWSchokkerSten HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
- RennardSDecramerMCalverleyPMImpact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J20022079980512412667
- MedbøAMelbyeHWhat role may symptoms play in the diagnosis of airflow limitation? A study in an elderly populationScand J Prim Health Care200826929818570007
- MethvinJNManninoDMCaseyBRCOPD prevalence in southeastern Kentucky: the Burden of Lung Disease studyChest200913510210718689574
- ChangJHLeeJHKimMKDeterminants of respiratory symptom development in patients with chronic airflow obstructionRespir Med20061002170217616675214
- WiltTJNiewoehnerDKimCUse of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)Evid Rep Technol Assess (Summ)200512117
- CasanovaCde TorresJPAguirre-JaímeAThe progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohortAm J Respir Crit Care Med20111841015102121836135
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669
- SeemungalTADonaldsonGCPaulEAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
- DecramerMCelliBKestenSEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
- CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
- CelliBDecramerMKestenSMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200918094895519729663
- O’DonnellDELavenezianaPOraJWebbKALamYMOfirDEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPDThorax20096421622319052054
- WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
- Echave-SustaetaJMCasanovaLCCosioBGSoler-CataluñaJJGarcia-LujanRRiberaXComorbidity in chronic obstructive pulmonary disease: related to disease severity?Int J Chron Obstruct Pulmon Dis201491307131425429213
- RisserNLBelcherDWAdding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trialJ Gen Intern Med1990516222405112